PepGen Inc. Common Stock
Symbol: PEPG (NASDAQ)
Company Description:
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.
- Today's Open: $2.1
- Today's High: $2.11
- Today's Low: $1.842
- Today's Volume: 763.92K
- Yesterday Close: $2.05
- Yesterday High: $2.145
- Yesterday Low: $1.85
- Yesterday Volume: 917.89K
- Last Min Volume: 400
- Last Min High: $1.875
- Last Min Low: $1.875
- Last Min VWAP: $1.875
- Name: PepGen Inc. Common Stock
- Website: https://www.pepgen.com
- Listed Date: 2022-05-06
- Location: BOSTON, MA
- Market Status: Active
- CIK Number: 0001835597
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $61.66M
- Round Lot: 100
- Outstanding Shares: 32.80M
- Asset Type: CS
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-13 | SCHEDULE 13G/A | View |
| 2025-08-07 | 8-K | View |
| 2025-08-07 | 10-Q | View |
| 2025-06-06 | 4 | View |
| 2025-06-06 | 8-K | View |
| 2025-06-06 | 4 | View |
| 2025-06-06 | 4 | View |
| 2025-06-06 | 4 | View |
| 2025-06-06 | 4 | View |
| 2025-06-06 | 4 | View |
| 2025-06-02 | 4 | View |
| 2025-05-28 | 8-K | View |
| 2025-05-21 | 4 | View |
| 2025-05-21 | 3 | View |
| 2025-05-15 | SCHEDULE 13G/A | View |
| 2025-05-15 | SCHEDULE 13G/A | View |
| 2025-05-08 | 8-K | View |
| 2025-05-08 | 10-Q | View |
| 2025-04-25 | ARS | View |
| 2025-04-25 | DEFA14A | View |